Cancer costs UK economy £16bn

The UK economy loses almost £16bn a year to cancer through healthcare costs, premature deaths and lost working days, according to the latest research.

Smoking: lung cancer costs NHS £2.4bn a year
Smoking: lung cancer costs NHS £2.4bn a year

Oxford University research, presented to the National Cancer Research Institute (NCRI) conference in Liverpool on Wednesday, found cancers cost the UK £15.8bn each year.

Around £7.6bn is lost due to premature deaths and time off work and £2.6bn from unpaid caring by family and friends. Just over a third of the actual cost of cancer - £5.6bn - is spent on healthcare.

Each lung cancer patient costs the NHS £9,071 annually with total costs to the economy of £2.4bn - more than any other cancer.

Researchers suggested greater priority should be given to help people stop smoking, which causes more than eight in 10 cases.

Research lead Dr Jose Leal of the Health Economics Research Centre at Oxford University said: 'Our research shows that cancers impact the economy as a whole - and not just the health service.'

He said the wider economic costs should be factored into deciding research priorities.

Dr Jane Cope, director of the NCRI, said: 'These figures remind us that cancer has a cost, not just in professional healthcare but also in loss of earnings for patients, and for loved ones who give up work to look after them. Since 86% of lung cancer deaths are linked to smoking, we can reduce these financial and societal costs by helping people to stop smoking.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...

Coronavirus

How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...